ATA Guidelines Tools

Thyroid Disease in Preconception, Pregnancy, and Postpartum

American Thyroid Association Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/1545288

Contents of this Issue

Navigation

Page 49 of 53

Thyroid Dysfunction Postpartum 50 Figure 7. Trajectories of Postpartum Thyroiditis Subtypes Example of postpartum exacerbation of Graves' disease Delivery Month 2 Month 4 Month 6–8 - β-blocker if symptomatic - No indication for antithyroid drugs - Levothyroxine therapy - Taper dosage after 6–12 months to assess recovery Serum thyroid hormone concentrations a Up to 50% of women who initially return to a euthyroid state will develop chronic hypothyroidism later in life. e typical trends of thyroid hormone trends seen in various subtypes of postpartum thyroiditis are summarized. During the thyrotoxic phases of the destructive subtypes, antithyroid drugs are not indicated, as the underlying etiolog y is not increased thyroid hormone production (as compared to the postpartum recurrence or exacerbation of Graves' disease, shown in the gray dotted line). During the hypothyroid phase of thyroiditis, a short course of thyroid hormone replacement may be considered in women with profound symptoms of hypothyroidism, with the plan to taper or stop the dose aer 6–12 months. Postpartum Thyroiditis Subtypes a Destructive thyroiditis (50%) Biphasic destructive thyroiditis (20%) Transient hypothyroidism (25%) Permanent hypothyroidism (5%)

Articles in this issue

Archives of this issue

view archives of ATA Guidelines Tools - Thyroid Disease in Preconception, Pregnancy, and Postpartum